Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,987 | 26,245 | 26,284 | 43,088 | 32,712 |
| Receivables | 9,036 | 8,603 | 7,679 | 5,065 | 3,656 |
| Other current assets | 4,495 | 4,636 | 5,720 | 5,181 | 7,245 |
| TOTAL | $32,518 | $39,484 | $39,683 | $53,334 | $43,613 |
| Non-Current Assets | |||||
| PPE Net | 24,817 | 27,828 | 27,867 | 5,848 | 4,179 |
| Intangibles | 18,914 | 20,905 | 22,942 | 24,828 | 26,648 |
| Other Non-Current Assets | 11,227 | 9,027 | 8,604 | 8,896 | 1,657 |
| TOTAL | $54,958 | $57,760 | $59,413 | $39,572 | $32,484 |
| Total Assets | $87,476 | $97,244 | $99,096 | $92,906 | $76,097 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6 | 21 | 51 | 49 | 19 |
| Accounts payable and accrued liabilities | 3,080 | 2,194 | 2,929 | 1,685 | 1,662 |
| Accrued Expenses | 11,033 | 10,064 | 7,710 | 8,218 | 7,665 |
| Other current liabilities | 992 | 641 | 22,150 | 10,382 | 17,764 |
| TOTAL | $17,436 | $14,317 | $33,416 | $22,839 | $28,960 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,445 | 36,408 | 35,225 | 25,004 | 9,993 |
| Deferred Revenues | 961 | 678 | 324 | 962 | 1,850 |
| Other Non-Current Liabilities | 25,060 | 25,643 | 25,875 | 24,457 | 17,417 |
| TOTAL | $72,505 | $62,051 | $61,100 | $49,461 | $27,410 |
| Total Liabilities | $89,941 | $76,368 | $94,516 | $72,300 | $56,370 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,858 | 7,299 | 4,847 | 3,899 | 1,565 |
| Common Shares | 8 | 7 | 96 | 78 | 31 |
| Retained earnings | -497,762 | -462,497 | -419,566 | -367,420 | -301,973 |
| TOTAL | $-2,465 | $20,876 | $4,580 | $20,606 | $19,727 |
| Total Liabilities And Equity | $87,476 | $97,244 | $99,096 | $92,906 | $76,097 |